REGENXBIO Inc. (RGNX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
License revenue								5.0
Other								2.6
Total revenues [+]	112.7	470.3	154.6	35.2	176.1	1.1	4.6	7.6
Licensing								5.0
Grants								0.3
Other								0.3
Revenue growth [+]	-76.0%	204.3%	338.7%	-80.0%	16668.2%	-77.1%	-39.5%	24.0%
License revenue								15.4%
Cost of goods sold [+]	54.5	51.8	35.7	8.2	9.6	1.7	1.0	1.5
Cost of product sales								0.1
Cost of licensing								1.4
Gross profit	58.2	418.5	118.9	27.0	166.4	-0.7	3.6	6.1
Gross margin	51.6%	89.0%	76.9%	76.6%	94.5%	-62.8%	79.1%	80.2%
Selling, general and administrative [+]	321.1	258.5	238.1	51.8	36.9	27.2	23.6	11.9
General and administrative				51.8	36.9	27.2	23.6	11.9
Research and development				124.2	83.9	57.2	45.5	17.3
Other operating expenses	17.0	18.7	-13.4	0.0	-42.4	-9.2	-0.1	0.0
EBITDA [+]	-266.9	150.9	-97.4	-141.8	92.1	-73.2	-64.8	-23.1
EBITDA growth	-276.9%	-254.9%	-31.3%	-254.0%	-225.8%	13.0%	181.0%	526.2%
EBITDA margin	-236.8%	32.1%	-63.0%	-402.6%	52.3%	-6971.3%	-1412.0%	-303.9%
Depreciation and amortization	12.9	9.6	8.4	7.2	4.0	2.7	0.5	0.1
EBIT [+]	-279.8	141.3	-105.8	-149.0	88.1	-75.9	-65.3	-23.1
EBIT growth	-298.0%	-233.5%	-29.0%	-269.1%	-216.1%	16.1%	182.4%	528.4%
EBIT margin	-248.2%	30.0%	-68.5%	-422.9%	50.0%	-7227.1%	-1423.8%	-304.9%
Interest income, net [+]	5.4	6.8	9.7	48.6	7.1	2.7	1.9	0.3
Interest expense	23.3	26.3	0.8					0.0
Interest income	5.4	6.8	9.7	48.6	7.1	2.7	1.9	0.3
Other income (expense), net [+]	17.3	19.4	-9.1	3.0	8.9
Other	-0.6	-0.1	-0.2
Pre-tax income	-280.4	141.2	-106.0	-97.5	104.1	-73.2	-63.4	-22.8
Income taxes	-0.1	13.4	5.2	-2.8	4.2	0.0	-0.4	0.0
Tax rate	0.0%	9.5%		2.8%	4.0%	0.0%	0.7%	0.0%
Net income	-280.3	127.8	-111.3	-94.7	99.9	-73.2	-63.0	-23.8
Net margin	-248.7%	27.2%	-72.0%	-268.9%	56.8%	-6968.5%	-1372.1%	-313.6%

Basic EPS [+]	($6.50)	$3.01	($2.98)	($2.58)	$2.99	($2.45)	($2.38)	($2.59)
Growth	-315.6%	-200.9%	15.6%	-186.4%	-222.1%	2.7%	-8.1%	42.3%
Diluted EPS [+]	($6.50)	$2.91	($2.98)	($2.58)	$2.73	($2.45)	($2.38)	($2.59)
Growth	-323.1%	-197.6%	15.6%	-194.7%	-211.4%	2.7%	-8.1%	42.3%

Shares outstanding (basic) [+]	43.2	42.4	37.3	36.7	33.4	29.9	26.4	9.2
Growth	1.7%	13.8%	1.6%	9.8%	11.9%	13.1%	187.9%	247.1%
Shares outstanding (diluted) [+]	43.2	43.9	37.3	36.7	36.6	29.9	26.4	9.2
Growth	-1.7%	17.8%	1.6%	0.1%	22.7%	13.1%	187.9%	247.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.